期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 186, 期 10, 页码 2588-2600出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2016.06.015
关键词
-
类别
资金
- NIH/National Eye Institute [R01 EY024963]
- Boston Children's Hospital Ophthalmology Foundation
- Massachusetts Lions Eye Research Fund, Inc.
- Alcon Research Institute
- Chinese Taiwan Ministry of Science and Technology Postdoctoral Research Abroad Fellowship [104-2917-I-564-026]
- NIH [RO1-GM057603, RO1-AR060359]
- Boston Children's Hospital Intellectual and Developmental Disabilities Research Center - NIH [P30 HD-18655]
Familial exudative vitreoretinopathy (FEVR) is characterized by delayed retinal vascular development, which promotes hypoxia-induced pathologic vessels. In severe cases FEVR may lead to retinal detachment and visual impairment. Genetic studies linked FEVR with mutations in Wnt signaling ligand or receptors, including low-density lipoprotein receptor-related protein 5 (LRP5) gene. Here, we investigated ocular pathologies in a Lrp5 knockout (Lrp5(-/-)) mouse model of FEVR and explored whether treatment with a pharmacologic Wnt activator lithium could bypass the genetic defects, thereby protecting against eye pathologies. Lrp5(-/-) mice displayed significantly delayed retinal vascular development, absence of deep layer retinal vessels, leading to increased levels of vascular endothelial growth factor and subsequent pathologic glomeruloid vessels, as well as decreased inner retinal visual function. Lithium treatment in Lrp5(-/-) mice significantly restored the delayed development of retinal vasculature and the intralaminar capillary networks, suppressed formation of pathologic glomeruloid structures, and promoted hyaloid vessel regression. Moreover, lithium treatment partially rescued inner-retinal visual function and increased retinal thickness. These protective effects of lithium were largely mediated through restoration of canonical Wnt signaling in Lrp5(-/-) retina. Lithium treatment also substantially increased vascular tubular formation in LRP5-deficient endothelial cells. These findings suggest that pharmacologic activation of Wnt signaling may help treat ocular pathologies in FEVR and potentially other defective Wnt signaling-related diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据